Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
02 2023
Historique:
received: 28 01 2022
accepted: 09 12 2022
pubmed: 27 1 2023
medline: 16 2 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder with a major genetic component. Here, we present a genome-wide association study meta-analysis of ADHD comprising 38,691 individuals with ADHD and 186,843 controls. We identified 27 genome-wide significant loci, highlighting 76 potential risk genes enriched among genes expressed particularly in early brain development. Overall, ADHD genetic risk was associated with several brain-specific neuronal subtypes and midbrain dopaminergic neurons. In exome-sequencing data from 17,896 individuals, we identified an increased load of rare protein-truncating variants in ADHD for a set of risk genes enriched with probable causal common variants, potentially implicating SORCS3 in ADHD by both common and rare variants. Bivariate Gaussian mixture modeling estimated that 84-98% of ADHD-influencing variants are shared with other psychiatric disorders. In addition, common-variant ADHD risk was associated with impaired complex cognition such as verbal reasoning and a range of executive functions, including attention.

Identifiants

pubmed: 36702997
doi: 10.1038/s41588-022-01285-8
pii: 10.1038/s41588-022-01285-8
doi:

Types de publication

Meta-Analysis Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

198-208

Subventions

Organisme : NIMH NIH HHS
ID : R37 MH107649
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH087004
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109514
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH116442
Pays : United States

Investigateurs

Alexandra Havdahl (A)
Alysa Doyle (A)
Andreas Reif (A)
Anita Thapar (A)
Bru Cormand (B)
Calwing Liao (C)
Christie Burton (C)
Claiton H D Bau (CHD)
Diego Luiz Rovaris (DL)
Edmund Sonuga-Barke (E)
Elizabeth Corfield (E)
Eugenio Horacio Grevet (EH)
Henrik Larsson (H)
Ian R Gizer (IR)
Irwin Waldman (I)
Isabell Brikell (I)
Jan Haavik (J)
Jennifer Crosbie (J)
James McGough (J)
Jonna Kuntsi (J)
Joseph Glessner (J)
Kate Langley (K)
Klaus-Peter Lesch (KP)
Luis Augusto Rohde (LA)
Mara H Hutz (MH)
Marieke Klein (M)
Mark Bellgrove (M)
Martin Tesli (M)
Michael C O'Donovan (MC)
Ole Andreas Andreassen (OA)
Patrick W L Leung (PWL)
Pedro M Pan (PM)
Ridha Joober (R)
Russel Schachar (R)
Sandra Loo (S)
Stephanie H Witt (SH)
Ted Reichborn-Kjennerud (T)
Tobias Banaschewski (T)
Ziarih Hawi (Z)
Mark J Daly (MJ)
Ole Mors (O)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Faraone, S. V. et al. Attention-deficit/hyperactivity disorder. Nat. Rev. Dis. Prim. 1, 15020 (2015).
pubmed: 27189265 doi: 10.1038/nrdp.2015.20
Franke, B. et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol. Psychiatry 17, 960–987 (2012).
pubmed: 22105624 doi: 10.1038/mp.2011.138
Dalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S. & Simonsen, M. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. Lancet Psychiatry 2, 702–709 (2015).
pubmed: 26249301 doi: 10.1016/S2215-0366(15)00271-0
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjolander, A. & Larsson, H. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry 71, 319–325 (2014).
pubmed: 24477798 pmcid: 3949159 doi: 10.1001/jamapsychiatry.2013.4174
Babinski, D. E., Neely, K. A., Ba, D. M. & Liu, G. Depression and suicidal behavior in young adult men and women with ADHD: evidence from claims data. J. Clin. Psychiatry 81, 19m13130 (2020).
pubmed: 32965804 pmcid: 7540206 doi: 10.4088/JCP.19m13130
Capusan, A. J., Bendtsen, P., Marteinsdottir, I. & Larsson, H. Comorbidity of adult ADHD and its subtypes with substance use disorder in a large population-based epidemiological study. J. Atten. Disord. 23, 1416–1426 (2019).
pubmed: 26838558 doi: 10.1177/1087054715626511
Boomsma, D. I., van Beijsterveldt, T., Odintsova, V. V., Neale, M. C. & Dolan, C. V. Genetically informed regression analysis: application to aggression prediction by inattention and hyperactivity in children and adults. Behav. Genet. 51, 250–263 (2021).
pubmed: 33259025 doi: 10.1007/s10519-020-10025-9
Dalsgaard, S., Ostergaard, S. D., Leckman, J. F., Mortensen, P. B. & Pedersen, M. G. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 385, 2190–2196 (2015).
pubmed: 25726514 doi: 10.1016/S0140-6736(14)61684-6
Jangmo, A. et al. Attention-deficit/hyperactivity disorder and occupational outcomes: the role of educational attainment, comorbid developmental disorders, and intellectual disability. PLoS ONE 16, e0247724 (2021).
pubmed: 33730071 pmcid: 7968636 doi: 10.1371/journal.pone.0247724
Zhao, X. et al. Family burden of raising a child with ADHD. J. Abnorm. Child Psychol. 47, 1327–1338 (2019).
pubmed: 30796648 doi: 10.1007/s10802-019-00518-5
Le, H. H. et al. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur. Child Adolesc. Psychiatry 23, 587–598 (2014).
pubmed: 24166532 doi: 10.1007/s00787-013-0477-8
Libutzki, B. et al. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis. Eur. Psychiatry 58, 38–44 (2019).
pubmed: 30802682 doi: 10.1016/j.eurpsy.2019.01.019
Faraone, S. V. & Larsson, H. Genetics of attention deficit hyperactivity disorder. Mol. Psychiatry 24, 562–575 (2019).
pubmed: 29892054 doi: 10.1038/s41380-018-0070-0
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
pubmed: 30478444 doi: 10.1038/s41588-018-0269-7
Pedersen, C. B. et al. The iPSYCH2012 case-cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol. Psychiatry 23, 6–14 (2018).
pubmed: 28924187 doi: 10.1038/mp.2017.196
Mattheisen, M. et al. Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups. Nat. Genet. 54, 1470–1478 (2022).
pubmed: 36163277 doi: 10.1038/s41588-022-01171-3
Satterstrom, F. K. et al. Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants. Nat. Neurosci. 22, 1961–1965 (2019).
pubmed: 31768057 pmcid: 6884695 doi: 10.1038/s41593-019-0527-8
Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 53, 817–829 (2021).
pubmed: 34002096 pmcid: 8192451 doi: 10.1038/s41588-021-00857-4
Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019).
pubmed: 30718901 pmcid: 6522363 doi: 10.1038/s41593-018-0326-7
Pardinas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
pubmed: 29483656 pmcid: 5918692 doi: 10.1038/s41588-018-0059-2
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363 doi: 10.1016/j.ajhg.2010.11.011
Trzaskowski, M. et al. Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 180, 439–447 (2019).
pubmed: 30708398 pmcid: 6675638 doi: 10.1002/ajmg.b.32713
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5
Koopmans, F. et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron 103, 217–234.e4 (2019).
pubmed: 31171447 pmcid: 6764089 doi: 10.1016/j.neuron.2019.05.002
Xie, Z. et al. Gene set knowledge discovery with enrichr. Curr. Protoc. 1, e90 (2021).
pubmed: 33780170 pmcid: 8152575 doi: 10.1002/cpz1.90
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
pubmed: 27141961 pmcid: 4987924 doi: 10.1093/nar/gkw377
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Zhang, W. et al. Integrative transcriptome imputation reveals tissue-specific and shared biological mechanisms mediating susceptibility to complex traits. Nat. Commun. 10, 3834 (2019).
pubmed: 31444360 pmcid: 6707297 doi: 10.1038/s41467-019-11874-7
Wang, D. et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 362, eaat8464 (2018).
pubmed: 30545857 pmcid: 6413328 doi: 10.1126/science.aat8464
Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).
pubmed: 29632380 pmcid: 5896795 doi: 10.1038/s41588-018-0081-4
Meuleman, W. et al. Index and biological spectrum of human DNase I hypersensitive sites. Nature 584, 244–251 (2020).
pubmed: 32728217 pmcid: 7422677 doi: 10.1038/s41586-020-2559-3
Corces, M. R. et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases. Nat. Genet. 52, 1158–1168 (2020).
pubmed: 33106633 pmcid: 7606627 doi: 10.1038/s41588-020-00721-x
Watanabe, K., Umicevic Mirkov, M., de Leeuw, C. A., van den Heuvel, M. P. & Posthuma, D. Genetic mapping of cell type specificity for complex traits. Nat. Commun. 10, 3222 (2019).
pubmed: 31324783 pmcid: 6642112 doi: 10.1038/s41467-019-11181-1
La Manno, G. et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167, 566–580.e19 (2016).
pubmed: 27716510 pmcid: 5055122 doi: 10.1016/j.cell.2016.09.027
Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).
pubmed: 27663502 doi: 10.1093/bioinformatics/btw613
Frei, O. et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat. Commun. 10, 2417 (2019).
pubmed: 31160569 pmcid: 6547727 doi: 10.1038/s41467-019-10310-0
Franke, B. et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur. Neuropsychopharmacol. 28, 1059–1088 (2018).
pubmed: 30195575 pmcid: 6379245 doi: 10.1016/j.euroneuro.2018.08.001
Satterthwaite, T. D. et al. Neuroimaging of the Philadelphia Neurodevelopmental Cohort. Neuroimage 86, 544–553 (2014).
pubmed: 23921101 doi: 10.1016/j.neuroimage.2013.07.064
Calkins, M. E. et al. The Philadelphia Neurodevelopmental Cohort: constructing a deep phenotyping collaborative. J. Child Psychol. Psychiatry 56, 1356–1369 (2015).
pubmed: 25858255 pmcid: 4598260 doi: 10.1111/jcpp.12416
Gur, R. C. et al. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology 26, 251–265 (2012).
pubmed: 22251308 pmcid: 3295891 doi: 10.1037/a0026712
Wilkinson, G. S. & Robertson, G. J. Wide Range Achievement Test (WRAT4) (Psychological Assessment Resources, 2006).
Uffelmann, E. et al. Genome-wide association studies. Nat. Rev. Methods Prim. 1, 59 (2021).
doi: 10.1038/s43586-021-00056-9
Bataillon, T. et al. The effective size of the Icelandic population and the prospects for LD mapping: inference from unphased microsatellite markers. Eur. J. Hum. Genet. 14, 1044–1053 (2006).
doi: 10.1038/sj.ejhg.5201669
Gazal, S. et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421–1427 (2017).
pubmed: 28892061 pmcid: 6133304 doi: 10.1038/ng.3954
Hindley, G. et al. The shared genetic basis of mood instability and psychiatric disorders: a cross-trait genome-wide association analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 189, 207–218 (2022).
pubmed: 35841185 pmcid: 9541703 doi: 10.1002/ajmg.b.32907
Plana-Ripoll, O. et al. Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry 76, 259–270 (2019).
pubmed: 30649197 pmcid: 6439836 doi: 10.1001/jamapsychiatry.2018.3658
Zablotsky, B., Bramlett, M. D. & Blumberg, S. J. The co-occurrence of autism spectrum disorder in children with ADHD. J. Atten. Disord. 24, 94–103 (2020).
pubmed: 28614965 doi: 10.1177/1087054717713638
Jensen, C. M. & Steinhausen, H. C. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten. Defic. Hyperact. Disord. 7, 27–38 (2015).
pubmed: 24942707 doi: 10.1007/s12402-014-0142-1
Chen, Q. et al. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: a population-based cross-sectional study. PLoS ONE 13, e0204516 (2018).
pubmed: 30256837 pmcid: 6157884 doi: 10.1371/journal.pone.0204516
Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell 179, 1469–1482.e11 (2019).
pmcid: 7077032 doi: 10.1016/j.cell.2019.11.020
Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112–1121 (2018).
pubmed: 30038396 pmcid: 6393768 doi: 10.1038/s41588-018-0147-3
Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Controls 19, 716–723 (1974).
doi: 10.1109/TAC.1974.1100705
Yao, X. et al. Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders. Transl. Psychiatry 11, 69 (2021).
pubmed: 33479212 pmcid: 7820351 doi: 10.1038/s41398-020-01195-5
Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502–508 (2022).
pubmed: 35396580 pmcid: 9392466 doi: 10.1038/s41586-022-04434-5
Johnson, E. C. et al. A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry 7, 1032–1045 (2020).
pubmed: 33096046 pmcid: 7674631 doi: 10.1016/S2215-0366(20)30339-4
Araujo, D. J. et al. FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. Genes Dev. 29, 2081–2096 (2015).
pubmed: 26494785 pmcid: 4617974 doi: 10.1101/gad.267989.115
Fong, W. L., Kuo, H. Y., Wu, H. L., Chen, S. Y. & Liu, F. C. Differential and overlapping pattern of Foxp1 and Foxp2 expression in the striatum of adult mouse brain. Neuroscience 388, 214–223 (2018).
pubmed: 30031127 doi: 10.1016/j.neuroscience.2018.07.017
Sollis, E. et al. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders. Hum. Mutat. 38, 1542–1554 (2017).
pubmed: 28741757 doi: 10.1002/humu.23303
Mostafavi, H., Spence, J. P., Naqvi, S. & Pritchard, J. K. Limited overlap of eQTLs and GWAS hits due to systematic differences in discovery. Preprint at bioRxiv https://doi.org/10.1101/2022.05.07.491045 (2022).
Satterstrom, F. K. et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell 180, 568–584.e23 (2020).
pubmed: 31981491 pmcid: 7250485 doi: 10.1016/j.cell.2019.12.036
Singh, T. et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, 509–516 (2022).
pubmed: 35396579 pmcid: 9805802 doi: 10.1038/s41586-022-04556-w
Sazonovs, A. et al. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. Nat. Genet. 54, 1275–1283 (2021).
doi: 10.1038/s41588-022-01156-2
Bahmani, Z. et al. Prefrontal contributions to attention and working memory. Curr. Top. Behav. Neurosci. 41, 129–153 (2019).
pubmed: 30739308 doi: 10.1007/7854_2018_74
Sonne, J., Reddy, V. & Beato, M. R. Substantia nigra. in StatPearls (StatPearls Publishing, 2021).
Morales, M. & Margolis, E. B. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat. Rev. Neurosci. 18, 73–85 (2017).
pubmed: 28053327 doi: 10.1038/nrn.2016.165
Chang, S., Yang, L., Wang, Y. & Faraone, S. V. Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders. Transl. Psychiatry 10, 182 (2020).
pubmed: 32518222 pmcid: 7283259 doi: 10.1038/s41398-020-00872-9
Nigg, J. T. et al. Working memory and vigilance as multivariate endophenotypes related to common genetic risk for attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 57, 175–182 (2018).
pubmed: 29496126 pmcid: 6547382 doi: 10.1016/j.jaac.2017.12.013
Aguilar-Lacasana, S. et al. Polygenic risk for ADHD and ASD and their relation with cognitive measures in school children. Psychol. Med. 52, 1356–1364 (2022).
pubmed: 32924895 doi: 10.1017/S0033291720003189
Martin, J., Hamshere, M. L., Stergiakouli, E., O’Donovan, M. C. & Thapar, A. Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder. J. Child Psychol. Psychiatry 56, 648–656 (2015).
pubmed: 25280069 doi: 10.1111/jcpp.12336
Bybjerg-Grauholm, J. et al. The iPSYCH2015 case-cohort sample: updated directions for unravelling genetic and environmental architectures of severe mental disorders. Preprint at medRxiv https://doi.org/10.1101/2020.11.30.20237768 (2020).
Mors, O., Perto, G. P. & Mortensen, P. B. The Danish psychiatric central research register. Scand. J. Public Health 39, 54–57 (2011).
pubmed: 21775352 doi: 10.1177/1403494810395825
Lynge, E., Sandegaard, J. L. & Rebolj, M. The Danish national patient register. Scand. J. Public Health 39, 30–33 (2011).
pubmed: 21775347 doi: 10.1177/1403494811401482
Price, A. L. et al. The impact of divergence time on the nature of population structure: an example from Iceland. PLoS Genet. 5, e1000505 (2009).
pubmed: 19503599 pmcid: 2684636 doi: 10.1371/journal.pgen.1000505
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
pubmed: 26773131 pmcid: 4866522 doi: 10.1093/bioinformatics/btw018
Greenbaum, J. & Deng, H. W. A statistical approach to fine mapping for the identification of potential causal variants related to bone mineral density. J. Bone Miner. Res. 32, 1651–1658 (2017).
pubmed: 28425624 doi: 10.1002/jbmr.3154
Chen, W. et al. Fine mapping causal variants with an approximate Bayesian method using marginal test statistics. Genetics 200, 719–736 (2015).
pubmed: 25948564 pmcid: 4512539 doi: 10.1534/genetics.115.176107
Wang, J. et al. CAUSALdb: a database for disease/trait causal variants identified using summary statistics of genome-wide association studies. Nucleic Acids Res. 48, D807–D816 (2020).
pubmed: 31691819
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Gandal, M. J. et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362, eaat8127 (2018).
pubmed: 30545856 pmcid: 6443102 doi: 10.1126/science.aat8127
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836 doi: 10.1038/ng.3656
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
pubmed: 27548312 pmcid: 5388176 doi: 10.1038/ng.3643
Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285 doi: 10.1038/ng.3404
Liu, M. et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet. 51, 237–244 (2019).
pubmed: 30643251 pmcid: 6358542 doi: 10.1038/s41588-018-0307-5
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641–3649 (2018).
pubmed: 30124842 pmcid: 6488973 doi: 10.1093/hmg/ddy271
Okbay, A. et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat. Genet. 54, 437–449 (2022).
pubmed: 35361970 pmcid: 9005349 doi: 10.1038/s41588-022-01016-z
Mills, M. C. et al. Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour. Nat. Hum. Behav. 5, 1717–1730 (2021).
pubmed: 34211149 pmcid: 7612120 doi: 10.1038/s41562-021-01135-3
Watanabe, K. et al. Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. Nat. Genet. 54, 1125–1132 (2022).
pubmed: 35835914 doi: 10.1038/s41588-022-01124-w
Als, T. D. et al. Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities. Preprint at medRxiv https://doi.org/10.1101/2022.08.24.22279149 (2022).
Ge, T., Chen, C. Y., Ni, Y., Feng, Y. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
pubmed: 30992449 pmcid: 6467998 doi: 10.1038/s41467-019-09718-5
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8

Auteurs

Ditte Demontis (D)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark. ditte@biomed.au.dk.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark. ditte@biomed.au.dk.
Center for Genomics and Personalized Medicine, Aarhus, Denmark. ditte@biomed.au.dk.

G Bragi Walters (GB)

deCODE Genetics/Amgen, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Georgios Athanasiadis (G)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Mental Health Centre Sct. Hans, Capital Region of Denmark, Institute of Biological Psychiatry, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Evolutionary Biology, Ecology and Environmental Sciences, University of Barcelona, Barcelona, Spain.

Raymond Walters (R)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Karen Therrien (K)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Trine Tollerup Nielsen (TT)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, Aarhus, Denmark.

Leila Farajzadeh (L)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, Aarhus, Denmark.

Georgios Voloudakis (G)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jaroslav Bendl (J)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Biau Zeng (B)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Wen Zhang (W)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jakob Grove (J)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.

Thomas D Als (TD)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, Aarhus, Denmark.

Jinjie Duan (J)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, Aarhus, Denmark.

F Kyle Satterstrom (FK)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Jonas Bybjerg-Grauholm (J)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.

Marie Bækved-Hansen (M)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.

Olafur O Gudmundsson (OO)

deCODE Genetics/Amgen, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Sigurdur H Magnusson (SH)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Gisli Baldursson (G)

Department of Child and Adolescent Psychiatry, National University Hospital, Reykjavik, Iceland.

Katrin Davidsdottir (K)

The Centre for Child Development and Behaviour, Capital Area Primary Health Care, Reykjavik, Iceland.

Gyda S Haraldsdottir (GS)

The Centre for Child Development and Behaviour, Capital Area Primary Health Care, Reykjavik, Iceland.

Esben Agerbo (E)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
National Centre for Register-Based Research, Business and Social Sciences, Aarhus University, Aarhus, Denmark.
Centre for Integrated Register-based Research, CIRRAU, Aarhus University, Aarhus, Denmark.

Gabriel E Hoffman (GE)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Søren Dalsgaard (S)

National Centre for Register-Based Research, Business and Social Sciences, Aarhus University, Aarhus, Denmark.
Mental Health Services of the Capital Region, Child and Adolescent Psychiatric Center, Glostrup, Denmark.
Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Joanna Martin (J)

Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Marta Ribasés (M)

Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.

Dorret I Boomsma (DI)

Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Maria Soler Artigas (M)

Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.

Nina Roth Mota (N)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.

Daniel Howrigan (D)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Sarah E Medland (SE)

Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Tetyana Zayats (T)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
PROMENTA, Department of Psychology, University of Oslo, Oslo, Norway.

Veera M Rajagopal (VM)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, Aarhus, Denmark.

Merete Nordentoft (M)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Mental Health Centre Copenhagen, Capital Region of Denmark, Copenhagen University Hospital, Copenhagen, Denmark.

Ole Mors (O)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.

David M Hougaard (DM)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.

Preben Bo Mortensen (PB)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
National Centre for Register-Based Research, Business and Social Sciences, Aarhus University, Aarhus, Denmark.
Centre for Integrated Register-based Research, CIRRAU, Aarhus University, Aarhus, Denmark.

Mark J Daly (MJ)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.

Stephen V Faraone (SV)

Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.

Hreinn Stefansson (H)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Panos Roussos (P)

Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mental Illness Research Education and Clinical Center, JJ Peters VA Medical Center, Bronx, NY, USA.

Barbara Franke (B)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.
Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.

Thomas Werge (T)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Mental Health Centre Sct. Hans, Capital Region of Denmark, Institute of Biological Psychiatry, Copenhagen University Hospital, Copenhagen, Denmark.

Benjamin M Neale (BM)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Kari Stefansson (K)

deCODE Genetics/Amgen, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Anders D Børglum (AD)

Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark. anders@biomed.au.dk.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark. anders@biomed.au.dk.
Center for Genomics and Personalized Medicine, Aarhus, Denmark. anders@biomed.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH